Epstein-Barr virus-associated methotrexate-induced accelerated rheumatoid nodulosis.
Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
Noriko
N
Shimoura
Atsushi
A
Fukunaga
Hiroshi
H
Nagai
Masahiro
M
Oka
Chikako
C
Nishigori
D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D001706:Biopsy; D020031:Epstein-Barr Virus Infections / Q000175:diagnosis / Q000276:immunology / Q000821:virology*; D005260:Female; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D006801:Humans; D016867:Immunocompromised Host; D007150:Immunohistochemistry; D008198:Lymph Nodes / Q000187:drug effects / Q000821:virology; D008727:Methotrexate / Q000009:adverse effects*; D012367:RNA, Viral / Q000302:isolation & purification; D012218:Rheumatoid Nodule / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology / Q000601:surgery / Q000821:virology*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D012367:RNA, Viral; D008727:Methotrexate